Webinar: Optimizing Amorphous Solid Dispersions, Overcoming Scale-Up Challenges with Next Generation Technologies
As the number of poorly soluble molecules entering the pipeline has increased, the application of amorphous solid dispersions development has grown. With the advent of next-generation ASD technologies, like KinetiSol™ Technology, drug developers are setting new standards in scalability, sustainability and performance.
In this webinar, expert speakers share their scale-up experiences and perspectives on opportunities to improve technology transfers for amorphous solid dispersions. They define best practices for a successful scale-up and a more complete and efficient tech transfer for the commercialization of amorphous solid dispersions.
Speakers:
Dr. Justin Keen, PhD, Senior Vice President, Operations, AustinPx
TJ Highley, MBA, CEO and Board Member, Microsize